HomeBLAC • NASDAQ
add
Bellevue Life Sciences Acquisition Corp
Previous close
$10.69
Day range
$10.70 - $10.76
Year range
$10.11 - $11.16
Market cap
60.19M USD
Avg Volume
23.83K
P/E ratio
204.74
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 861.89K | 5,947.53% |
Net income | -86.17K | -504.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 228.87% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.42K | -87.62% |
Total assets | 36.63M | 2,887.94% |
Total liabilities | 40.53M | 3,108.46% |
Total equity | -3.91M | — |
Shares outstanding | 5.62M | — |
Price to book | -15.49 | — |
Return on assets | -3.96% | — |
Return on capital | 70.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -86.17K | -504.63% |
Cash from operations | -279.49K | -29,258.51% |
Cash from investing | 36.38M | — |
Cash from financing | -36.14M | -63,932.58% |
Net change in cash | -42.54K | -176.41% |
Free cash flow | 556.71K | 340.72% |
About
Founded
2020
Headquarters
